None listed
Conditions
Interventions
Intervention 1: The control group does twelve sessions of activity without receiving supplements and placebo. Intervention 2: The intervention group does training sessions twelve with the receive of T
Prevention
Treatment - Drugs
Placebo
The control group does twelve sessions of activity without receiving supplements and placebo
The intervention group does training sessions twelve with the receive of Taurine supplementation
The placebo group does training sessions twelve with placebo receive.
Sponsors
Investigator
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: Inclusion criteria: Subjects the lack of particular diseases, especially liver and heart disease - respiratory. Exclusion criteria: People with specific diseases, especially heart disease and liver - respiratory.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Enzymes Superoxide dismutase. Timepoint: Two days before , The day begining of and on the last day of the intervention. Method of measurement: In a sandwich enzyme-linked immunosorbent assay. | — |
Secondary
| Measure | Time frame |
|---|---|
| No variable. Timepoint: not measurement. Method of measurement: not sampling. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Fathi
Lorestan University
Outcome results
None listed